domingo, 11 de septiembre de 2016

Advances in genetics: widening our understanding of prostate cancer. - PubMed - NCBI

Advances in genetics: widening our understanding of prostate cancer. - PubMed - NCBI

 2016 Jun 27;5. pii: F1000 Faculty Rev-1512. doi: 10.12688/f1000research.8019.1. eCollection 2016.

Advances in genetics: widening our understanding of prostate cancer.

Abstract

Prostate cancer is a leading cause of cancer-related death in Western men. Our understanding of the genetic alterations associated with disease predisposition, development, progression, and therapy response is rapidly improving, at least in part, owing to the development of next-generation sequencing technologies. Large advances have been made in our understanding of the genetics of prostate cancer through the application of whole-exome sequencing, and this review summarises recent advances in this field and discusses how exome sequencing could be used clinically to promote personalised medicine for prostate cancer patients.

KEYWORDS:

Androgen; Cancer progression; DNA damage repair; Metastasis; Personalised Medicine; Prostate Cancer; Transcriptome; WES; Whole Exome Sequencing

[PubMed] 
Free PMC Article

No hay comentarios:

Publicar un comentario